Cargando…

Performance of IOTA Simple Rules Risks, ADNEX Model, Subjective Assessment Compared to CA125 and HE4 with ROMA Algorithm in Discriminating between Benign, Borderline and Stage I Malignant Adnexal Lesions

BACKGROUND: Borderline ovarian tumors (BOTs) and early clinical stage malignant adnexal masses can make sonographic diagnosis challenging, while the clinical utility of tumor markers, e.g., CA125 and HE4, or the ROMA algorithm, remains controversial in such cases. OBJECTIVE: To compare the IOTA grou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Czekierdowski, Artur, Stachowicz, Norbert, Smolen, Agata, Łoziński, Tomasz, Guzik, Paweł, Kluz, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000903/ https://www.ncbi.nlm.nih.gov/pubmed/36900029 http://dx.doi.org/10.3390/diagnostics13050885

Ejemplares similares

Sonographic Assessment of Complex Ultrasound Morphology Adnexal Tumors in Pregnant Women with the Use of IOTA Simple Rules Risk and ADNEX Scoring Systems
por: Czekierdowski, Artur, et al.
Publicado: (2021)

Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
por: Terlikowska, Katarzyna M., et al.
Publicado: (2016)

Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses
por: Xie, Wen ting, et al.
Publicado: (2022)

Comparison of HE4, CA125, ROMA and CPH-I for Preoperative Assessment of Adnexal Tumors
por: Carreras-Dieguez, Núria, et al.
Publicado: (2022)

Validation of IOTA-ADNEX Model in Discriminating Characteristics of Adnexal Masses: A Comparison with Subjective Assessment
por: Jeong, Soo Young, et al.
Publicado: (2020)

Performance of the IOTA ADNEX Model on Selected Group of Patients with Borderline Ovarian Tumours
por: Gaurilcikas, Adrius, et al.
Publicado: (2020)

Surgical outcomes of adnexal masses classified by IOTA ultrasound simple rules
por: Carballo, Erica V., et al.
Publicado: (2022)

Conservative Management of Asymptomatic Adnexal Masses Classified as Benign by the IOTA ADNEX Model: A Prospective Multicenter Portuguese Study
por: Brito, Marta Espanhol, et al.
Publicado: (2021)

Practical guidance for applying the ADNEX model from the IOTA group to discriminate between different subtypes of adnexal tumors
por: Van Calster, B., et al.
Publicado: (2015)

Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group
por: Timmerman, Dirk, et al.
Publicado: (2010)

Performance of the IOTA ADNEX model combined with HE4 for identifying early-stage ovarian cancer
por: Yang, Suying, et al.
Publicado: (2022)

Evaluation of IOTA-ADNEX Model and Simple Rules for Identifying Adnexal Masses by Operators with Varying Levels of Expertise: A Single-Center Diagnostic Accuracy Study
por: Giourga, Maria, et al.
Publicado: (2023)

Response to letter to the editor concerning validation of IOTA ADNEX model
por: Szubert, Sebastian, et al.
Publicado: (2016)

O-RADS Classification for Ultrasound Assessment of Adnexal Masses: Agreement between IOTA Lexicon and ADNEX Model for Assigning Risk Group
por: Vara, Julio, et al.
Publicado: (2023)

Benign descriptors and ADNEX in two‐step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation in IOTA5 multicenter cohort
por: Landolfo, C., et al.
Publicado: (2023)

The International Ovarian Tumor Analysis-Assessment of Different Neoplasias in the Adnexa (IOTA-ADNEX) Model Assessment for Risk of Ovarian Malignancy in Adnexal Masses
por: Cherukuri, Srinidhi, et al.
Publicado: (2022)

Interobserver agreement between eight observers using IOTA simple rules and O-RADS lexicon descriptors for adnexal masses
por: Antil, Neha, et al.
Publicado: (2022)

Tumor budding index and microvessel density assessment in patients with endometrial cancer: A pilot study
por: Kluz, Tomasz, et al.
Publicado: (2020)

Risk Assessment of Endometrial Hyperplasia or Endometrial Cancer with Simplified Ultrasound-Based Scoring Systems
por: Stachowicz, Norbert, et al.
Publicado: (2021)

Adnexal Masses Suspected to Be Benign Treated with Laparoscopy
por: Demir, Richard H., et al.
Publicado: (2012)

Practical Recommendations for the Management of Benign Adnexal Masses
por: Rocha, Rodrigo Manieri, et al.
Publicado: (2020)

Evaluation of Probably Benign Adnexal Masses in Postmenopausal Women
por: Karakaya, Burcu Kisa, et al.
Publicado: (2017)

Comparative diagnostic accuracy of the IOTA SRR and LR2 scoring systems for discriminating between malignant and Benign Adnexal masses by junior physicians in Chinese patients: a retrospective observational study
por: Tian, Cai, et al.
Publicado: (2023)

Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies
por: Kaijser, J.
Publicado: (2015)

Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification
por: Pelayo, Mar, et al.
Publicado: (2023)

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

Comparison of Ultrasound and Tumor Marker CA125 in Diagnosis of Adnexal Mass Malignancies
por: Behnamfar, Fariba, et al.
Publicado: (2022)

Key findings from the International Ovarian Tumor Analysis (IOTA) study: an approach to the optimal ultrasound based characterisation of adnexal pathology
por: Kaijser, Jeroen, et al.
Publicado: (2015)

Benign vs. Malignant Skin Adnexal Neoplasms: How Useful are Silhouettes?
por: Tirumalae, Rajalakshmi, et al.
Publicado: (2013)

Microcystic adnexal carcinoma of the upper lip misdiagnosed benign desmoplastic trichoepithelioma
por: Rustemeyer, Jan, et al.
Publicado: (2012)

Mini-Laparoscopic Versus Conventional Laparoscopic Surgery for Benign Adnexal Masses
por: Gencdal, Servet, et al.
Publicado: (2017)

Comparison of Ultrasound Scores in Differentiating between Benign and Malignant Adnexal Masses
por: Pelayo, Mar, et al.
Publicado: (2023)

Comparison of ultrasound−based ADNEX model with magnetic resonance imaging for discriminating adnexal masses: a multi-center study
por: Hu, Yanli, et al.
Publicado: (2023)

The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
por: Dolgun, Zehra Nihal, et al.
Publicado: (2017)

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study
por: Van Calster, Ben, et al.
Publicado: (2014)

Adnexal mass with extremely high levels of CA-125 and CA19-9 but normal Human Epididymis Protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA): Endometriosis or ovarian malignancy? A case report
por: Khodaverdi, Sepideh, et al.
Publicado: (2018)

Diagnostic Added-Value of Serum CA-125 on the IOTA Simple Rules and Derivation of Practical Combined Prediction Models (IOTA SR X CA-125)
por: Phinyo, Phichayut, et al.
Publicado: (2021)

Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1–4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?
por: Abdalla, Nabil, et al.
Publicado: (2017)

Adnexal carcinomas of the head and neck
por: Güerrissi, Jorge O., et al.
Publicado: (2008)

Endoscopic Management of Adnexal Masses
por: Mettler, Liselotte, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_675ev4un3c3eqo25a7q22kaq2g